BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chow MYT, Qiu Y, Liao Q, Kwok PCL, Chow SF, Chan HK, Lam JKW. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin. Int J Pharm 2019;572:118818. [PMID: 31678379 DOI: 10.1016/j.ijpharm.2019.118818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng R, Zhu H, Wang Z, Hao S, Wang B, Pugazhendhi ​. Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy. Journal of Nanomaterials 2022;2022:1-12. [DOI: 10.1155/2022/3052175] [Reference Citation Analysis]
2 Wm Keil T, Deiringer N, Friess W, Merkel OM. Evaluation of adsorption of DNA/PEI polyplexes to tubing materials. Eur J Pharm Biopharm 2022:S0939-6411(22)00180-1. [PMID: 36041597 DOI: 10.1016/j.ejpb.2022.08.014] [Reference Citation Analysis]
3 Merkel OM. Can pulmonary RNA delivery improve our pandemic preparedness? Journal of Controlled Release 2022;345:549-56. [DOI: 10.1016/j.jconrel.2022.03.039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
5 Steinle H, Weber J, Stoppelkamp S, Große-Berkenbusch K, Golombek S, Weber M, Canak-Ipek T, Trenz SM, Schlensak C, Avci-Adali M. Delivery of synthetic mRNAs for tissue regeneration. Adv Drug Deliv Rev 2021;179:114007. [PMID: 34710530 DOI: 10.1016/j.addr.2021.114007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
6 Chang RYK, Chow MYT, Khanal D, Chen D, Chan HK. Dry powder pharmaceutical biologics for inhalation therapy. Adv Drug Deliv Rev 2021;172:64-79. [PMID: 33705876 DOI: 10.1016/j.addr.2021.02.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
7 Mehta A, Michler T, Merkel OM. siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies? Adv Healthc Mater 2021;10:e2001650. [PMID: 33506607 DOI: 10.1002/adhm.202001650] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 23.0] [Reference Citation Analysis]
8 Xu Y, Thakur A, Zhang Y, Foged C. Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 2021;13:177. [PMID: 33525500 DOI: 10.3390/pharmaceutics13020177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
9 Das S, Khadka P, Shah R, Mcgill S, Smyth H. Nanomedicine in pulmonary delivery. Theory and Applications of Nonparenteral Nanomedicines 2021. [DOI: 10.1016/b978-0-12-820466-5.00014-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Chow MYT, Chang RYK, Chan HK. Inhalation delivery technology for genome-editing of respiratory diseases. Adv Drug Deliv Rev 2021;168:217-28. [PMID: 32512029 DOI: 10.1016/j.addr.2020.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
11 Ding L, Tang S, Wyatt TA, Knoell DL, Oupický D. Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges. J Control Release 2021;330:977-91. [PMID: 33181203 DOI: 10.1016/j.jconrel.2020.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]